Literature DB >> 25115814

Oligodendroglial response in the spinal cord in TDP-43 proteinopathy with motor neuron involvement.

Zdenek Rohan1, Radoslav Matej, Robert Rusina, Gabor G Kovacs.   

Abstract

BACKGROUND: TDP-43 proteinopathies represent a spectrum of neurodegenerative disorders. Variable clinical presentations including frontotemporal dementia, amyotrophic lateral sclerosis (ALS) and mixed forms are associated with the spatial heterogeneity of the TDP-43 pathology. Recent studies have emphasized the role of oligodendrocytes in the pathogenesis of ALS.
OBJECTIVE: To evaluate whether TDP-43 proteinopathies are associated with an oligodendroglial response.
METHODS: We performed a study on 7 controls and 10 diseased patients with spinal cord involvement. Using the oligodendroglia-specific antibody TPPP/p25, we assessed oligodendrocyte density in the lateral corticospinal tracts (LCSs) along with the presence of perineuronal oligodendrocytes (PNOGs) in the anterior horns. We performed a densitometry of myelin basic protein (MBP) immunoreactivity. The numbers of TDP-43 and p62 immunoreactive inclusions were counted in both the LCSs and the anterior horns.
RESULTS: Double immunolabeling confirmed that oligodendrocytes harbor TDP-43 inclusions. In the LCSs, MBP density, but not the number of oligodendrocytes, was decreased in the diseased group. However, oligodendrocyte counts in the LCS correlated positively, and the density of MBP inversely, with the number of neuronal inclusions in the anterior horn, suggestive of a compensatory response of oligodendrocytes. The number of neurons with PNOGs correlated with the amount of inclusions.
CONCLUSION: Our study further emphasizes the importance of oligodendroglia in the pathogenesis of TDP-43 proteinopathies with spinal cord involvement.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25115814     DOI: 10.1159/000362929

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  12 in total

Review 1.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

2.  Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination.

Authors:  Jia Wang; Wan Yun Ho; Kenneth Lim; Jia Feng; Greg Tucker-Kellogg; Klaus-Armin Nave; Shuo-Chien Ling
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-29       Impact factor: 11.205

3.  Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair.

Authors:  Svitlana Garbuzova-Davis; Edward Haller; Stephanie Navarro; Tony E Besong; Kayla J Boccio; Surafuale Hailu; Mohammed Khatib; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Exp Neurol       Date:  2018-08-30       Impact factor: 5.330

4.  Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction.

Authors:  Audrey Yi Tyan Peng; Ira Agrawal; Wan Yun Ho; Yi-Chun Yen; Ashley J Pinter; Jerry Liu; Qi Xuan Cheryl Phua; Katrianne Bethia Koh; Jer-Cherng Chang; Emma Sanford; Jodie Hon Kiu Man; Peiyan Wong; David H Gutmann; Greg Tucker-Kellogg; Shuo-Chien Ling
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-30       Impact factor: 11.205

5.  Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43.

Authors:  Dongeun Heo; Jonathan P Ling; Gian C Molina-Castro; Abraham J Langseth; Ari Waisman; Klaus-Armin Nave; Wiebke Möbius; Phil C Wong; Dwight E Bergles
Journal:  Elife       Date:  2022-03-21       Impact factor: 8.713

6.  Quantitative patterns of motor cortex proteinopathy across ALS genotypes.

Authors:  Matthew Nolan; Connor Scott; Menuka Pallebage Gamarallage; Daniel Lunn; Kilda Carpenter; Elizabeth McDonough; Dan Meyer; Sireesha Kaanumalle; Alberto Santamaria-Pang; Martin R Turner; Kevin Talbot; Olaf Ansorge
Journal:  Acta Neuropathol Commun       Date:  2020-07-02       Impact factor: 7.801

7.  Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.

Authors:  Yuji Takahashi; Akiko Uchino; Ayako Shioya; Terunori Sano; Chihiro Matsumoto; Yurika Numata-Uematsu; Seiichi Nagano; Toshiyuki Araki; Shigeo Murayama; Yuko Saito
Journal:  Neuropathology       Date:  2019-05-24       Impact factor: 1.906

Review 8.  How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis.

Authors:  Roxane Crabé; Franck Aimond; Philippe Gosset; Frédérique Scamps; Cédric Raoul
Journal:  Cells       Date:  2020-11-27       Impact factor: 6.600

9.  Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states.

Authors:  Oliver J Ziff; Benjamin E Clarke; Doaa M Taha; Hamish Crerar; Nicholas M Luscombe; Rickie Patani
Journal:  Genome Res       Date:  2021-12-28       Impact factor: 9.043

Review 10.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.